Published in Br J Dermatol on April 01, 1992
The use of isotretinoin in acne. Dermatoendocrinol (2009) 1.06
Staphylococcus aureus hijacks a skin commensal to intensify its virulence: immunization targeting β-hemolysin and CAMP factor. J Invest Dermatol (2010) 1.01
Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris. Vaccine (2011) 0.87
Nasal vestibulitis due to targeted therapies in cancer patients. Support Care Cancer (2015) 0.79
A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea. Eur J Clin Microbiol Infect Dis (2016) 0.75
Is evidence for homoeopathy reproducible? Lancet (1994) 6.55
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A (1994) 4.21
Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ (2000) 4.10
Personal risk-factor chart for cutaneous melanoma. Lancet (1989) 2.65
Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Br Med J (Clin Res Ed) (1986) 2.49
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31
Umbilical cord clamping and preterm infants: a randomised trial. BMJ (1993) 2.17
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol (2004) 2.14
Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol (1996) 1.94
Tanning with ultraviolet A sunbeds. BMJ (1990) 1.93
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol (1985) 1.75
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer (2001) 1.72
Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev (2007) 1.66
Compliance with inhaled asthma medication in preschool children. Thorax (1995) 1.58
Juvenile plantar dermatosis: a new entity?. Clin Exp Dermatol (1976) 1.51
The effects of a 12-week group exercise programme on physiological and psychological variables and function in overweight women. Public Health (2004) 1.51
Cutaneous malignancy in males treated with photochemotherapy. Lancet (1990) 1.44
Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol (1994) 1.39
The suitability of SunCheck patches and Tanscan cards for monitoring the sunburning effectiveness of sunlight. Br J Dermatol (1993) 1.38
Health and the ozone layer. BMJ (1988) 1.37
UVA-induced melanocytic lesions. Br J Dermatol (1987) 1.35
Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet (1984) 1.34
An inner city preschool visual screening programme: long-term visual results. Br J Ophthalmol (1998) 1.21
Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol (1984) 1.14
Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol (2007) 1.10
Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol (1988) 1.09
Proposed alternative terminology and subclassification of so called "dysplastic naevi". J Clin Pathol (1986) 1.07
A comparison of the anthropometric, strength, endurance and flexibility characteristics of female elite and recreational climbers and non-climbers. J Sports Sci (2001) 1.06
Assessment of prognosis in patients with malignant melanoma. Lancet (1972) 1.05
Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl (1995) 1.05
Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol (1994) 1.04
Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol (1990) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol (1998) 1.03
Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer (2003) 1.02
Waiting times for and attendance at paediatric ophthalmology outpatient appointments. BMJ (1996) 1.00
Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med (1997) 0.99
Cell-mediated immunity in patients with malignant melanoma. Br J Dermatol (1972) 0.99
Bovine acute phase response following turpentine injection. Res Vet Sci (1988) 0.99
Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions. Br J Dermatol (1981) 0.98
Sensitization to tumour-associated antigens in human breast carcinoma. Int J Cancer (1974) 0.97
Sickness scoring and response to treatment as predictors of outcome from critical illness. Intensive Care Med (1988) 0.97
Seven-point checklist for melanoma. Clin Exp Dermatol (1991) 0.96
Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol (1992) 0.95
Angiosarcoma of the head and neck associated with xeroderma pigmentosum variant. Br J Dermatol (1999) 0.94
Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev (2007) 0.94
The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum Genet (2000) 0.93
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study. Br J Cancer (2001) 0.93
Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification. Br J Dermatol (2012) 0.93
Familial atrophia maculosa varioliformis cutis. Br J Dermatol (1996) 0.92
Effects of an energy and micronutrient supplement on anthropometry in undernourished children in Indonesia. Eur J Clin Nutr (2000) 0.92
Is it possible to predict the blood volume of a sick preterm infant? Arch Dis Child Fetal Neonatal Ed (2004) 0.92
False positive ECG reports of anterior myocardial infarction in women. J Electrocardiol (2000) 0.92
An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol (1998) 0.92
Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol (1998) 0.92
Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. Br J Cancer (1996) 0.91
Hyperplastic parathyroiditis--a new autoimmune disease? J Clin Pathol (1982) 0.90
Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev (2003) 0.89
Leukocyte migration inhibition by cancer patients' sera. Int J Cancer (1976) 0.89
Severe reaction to diphosphonate: implications for treatment of Paget's disease. BMJ (1988) 0.89
The prescription of isotretinoin to women: is every precaution taken? Br J Dermatol (1998) 0.88
Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol (1975) 0.88
Thick melanoma: the challenge persists. Br J Dermatol (2005) 0.88
A new 12-lead pediatric ECG interpretation program. J Electrocardiol (1990) 0.87
Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol (2000) 0.87
Changes in the site distribution of malignant melanoma in South East Scotland (1979-2002). Br J Cancer (2007) 0.87
Pulmonary cryptococcosis: report on the treatment of nine cases. Dis Chest (1969) 0.87
Tioconazole nail solution--an open study of its efficacy in onychomycosis. Clin Exp Dermatol (1985) 0.87
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol (1996) 0.87
Plantar malignant melanoma in a white Caucasian population. Br J Dermatol (1993) 0.87
Letter: Formalin-fixed tumour cells in the leukocyte migration test. Lancet (1973) 0.86
The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival. Br J Dermatol (2002) 0.86
The gene for hypotrichosis of Marie Unna maps between D8S258 and D8S298: exclusion of the hr gene by cDNA and genomic sequencing. Am J Hum Genet (1999) 0.86
An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol (1997) 0.86
The value of the coefficient of variation in assessing repeat variation in ECG measurements. Eur Heart J (1998) 0.86
An assessment of the diagnostic value of the monoclonal antibodies Leu 8, OKT9, OKT10 and Ki67 in cutaneous lymphocytic infiltrates. Br J Dermatol (1986) 0.85
Why are there delays in patients presenting with melanoma? Br J Dermatol (1999) 0.85
Pustular psoriasis in association with renal amyloidosis. Br J Dermatol (1974) 0.85
Cutaneous lymphangitis carcinomatosa: a rare primary manifestation of malignancy. J R Soc Med (1996) 0.85
Lupus erythematosus in association with finger-clubbing. Br J Dermatol (1973) 0.85
Measured bronchodilator use in preschool children with asthma. BMJ (1995) 0.85
The effect of treatment with 13-cis-retinoic acid on the metabolic burst of peripheral blood neutrophils from patients with acne. Br J Dermatol (1991) 0.85
Multiple primary melanoma: risk factors and prognostic implications. BMJ (1994) 0.84
Natural-killer-cell activity in atopic dermatitis. Clin Allergy (1984) 0.83
The effect of nebulised pentamidine on the concentration of intra-oral Candida albicans in HIV-infected patients. J Med Microbiol (1994) 0.83
Screening for the small-for-dates fetus: a two-stage ultrasonic examination schedule. Br Med J (1980) 0.83
The relationship between immunological parameters and response to therapy in resistant oral candidosis. Br J Dermatol (1978) 0.83
Formalinized tumour cells in the leucocyte migration inhibition test. Clin Exp Immunol (1975) 0.83
The desmoplastic melanocytic naevus: a distinct histological entity. Histopathology (1992) 0.82
A comparison of mobility assessments in a geriatric day hospital. Clin Rehabil (2001) 0.82
A novel case of follicular mucinosis after autologous stem-cell transplantation for multiple myeloma. Clin Exp Dermatol (2011) 0.82
Intravascular histiocytosis. Histopathology (1994) 0.81
Plasma zinc in psoriatic in-patients treated with local zinc applications. Br J Dermatol (1980) 0.81
Indirect leukocyte migration assay in patients with malignant melanoma. Int J Cancer (1979) 0.80
Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma. Br J Dermatol (1992) 0.80
First time marathoners and distance training. Br J Sports Med (1984) 0.80